Nuveen Asset Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 491,107 shares of APLS stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
491,107
Previous 340,723
44.14%
Holding current value
$12.2 Million
Previous $9.83 Million
59.49%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding APLS
# of Institutions
296Shares Held
132MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$305 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$296 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$253 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$243 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$224 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.74B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...